Through our immunohistochemical results, we could see that markers such as ACTA2, VIM, and MMP2 were mostly differentially expressed in the stromal area, including CAFs and vascular smooth muscle cells, but not in the tumor cells between the different risk score groups. The gene discussed is MMP2; the disease is neoplasm.